Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results Record fiscal year 2022 revenue of $1.34 billion and Adjusted EBITDA(1) of $305 million, representing an increase of 12% and 17% from fiscal 2021, respectively Fourth quarter 2022 Revenue of $352.5 million, representing an increase of 14% year-over-year, and Adjusted EBITDA(1) of $73 million Operating cash... Read more
Acreage Reports Fourth Quarter and Full Year 2022 Financial Results Record annual revenue of $237.1 million, a year-over-year increase of 26% and a 41% year-over-year increase in annual Adjusted EBITDA* Significant progress toward strategic goals, including divestiture of non-core assets, completion of cultivation expansions, enhancement of debt facilities, and... Read more
As we described in a previous article, the Global Cannabis Stock Index fell sharply in March, plunging 15.2%, leaving it down 12.5% in the first quarter of the year. This followed a record decline of 70.4% for 2022. In May, the index dropped again, falling 2.9% to 8.25 In this exclusive... Read more
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, The... Read more
